TrkB control peptide (54-67), Purified Peptide-100 µg Reference: PE-1252-100 This peptide may be used to block binding activity of antibody to TrkB (# R-121-100).
Parkin control peptide (305-323), Purified Peptide-100 µg Reference: PE-1253-100 This peptide may be used to block binding activity of antibody to Parkin (# R-113-100).
Alpha synuclein control peptide (116-131), Purified Peptide-100 µg Reference: PE-1606-100 Alpha synuclein control peptide (116-131), Purified Peptide, suitable to Block.
Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg Reference: PE-1749-50 Synthetic beta-amyloid Aβ1-42 was monomerized by HFIP (hexafluoro-2-propanol) treatment and dried. One vial contains 50 μg monomeric Aβ peptide that can be used to form solutions of unaggregated Aβ monomers, aggregated Aβ oligomers, Aβ fibrils and Aβ protein complexes according to published protocols, and used in a variety of research applications.
Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng Reference: PE-1750-1000 A proprietary preparation of human amyloid beta peptide (amino acids 1-42) that was initially monomerized by HFIP-treatment and then allowed to form oligomers by the procedure described in Youmans KL et al., 2012, followed by lyophilisation using Biosensis' proprietary stabilization procedures.The resulting oligomeric mixture has been specially designed to allow the formation of stable, oligomeric Aβ1-42 peptide, multimeric complexes or oligomers. The material is intended to be used as a stable and consistent standard or positive control for oligomeric ELISA assays, as well as other research applications.
Choline O-acetyltransferase (ChAT) control peptide (167-188), Purified... Reference: PE-1762-100 This peptide may be used to block binding activity of antibody to ChAT (# R-043-100 and # R-1621-100).
Recombinant Human Arylacetamide deacetylase(AADAC)，partial Reference: CSB-BP001014HU_100 Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity.
Recombinant Human Arylacetamide deacetylase(AADAC)，partial Reference: CSB-BP001014HU_20 Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity.
Recombinant Meleagris gallopavo Acrosin(ACR) Reference: CSB-BP001183MQV_500 Serine protease of trypsin-like cleavage specificity. Synthesized in a zymogen form, proacrosin and stored in the acrosome
Recombinant Meleagris gallopavo Acrosin(ACR) Reference: CSB-BP001183MQV_100 Serine protease of trypsin-like cleavage specificity. Synthesized in a zymogen form, proacrosin and stored in the acrosome
Recombinant Meleagris gallopavo Acrosin(ACR) Reference: CSB-BP001183MQV_20 Serine protease of trypsin-like cleavage specificity. Synthesized in a zymogen form, proacrosin and stored in the acrosome
Recombinant Human Actin, cytoplasmic 1(ACTB) Reference: CSB-BP001207HU_500 Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed:29925947).